Literature DB >> 7519585

Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells.

A L Veatch1, L F Carson, S Ramakrishnan.   

Abstract

Advanced ovarian cancers contain 2 distinct phenotypic populations: (a) free-floating tumor cells in the ascitic fluid and (b) solid tumors. Ascites cells are derived from the solid tumors and spread throughout the peritoneum. Changes in cell-cell and cell-extracellular matrix interactions are thought to be responsible for the origin of ascites cells. Since E-cadherin molecules play a crucial role in the cell-cell interactions in epithelial cells, we investigated the expression of E-cadherin in these 2 phenotypic populations. Paired samples of ascites and solid tumors were obtained from patients. Both primary tumors and tumor cells isolated from an experimental model showed a marked decrease in E-cadherin expression in the ascites cells compared to the respective solid tumors. Semi-quantitative, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to determine the steady-state levels of E-cadherin-specific mRNA. Results indicate that the primary tumors had significantly lower levels of E-cadherin transcript in ascites cells when compared to their solid tumor counterparts. Changes in E-cadherin expression were also reflected in the invasion capacity of tumor cells in vitro. Ascites cells were 4-fold more invasive then solid tumor cells, suggesting that ascites cells are a highly malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519585     DOI: 10.1002/ijc.2910580315

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  47 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Metastasis Organotropism: Redefining the Congenial Soil.

Authors:  Yang Gao; Igor Bado; Hai Wang; Weijie Zhang; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

3.  Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9.

Authors:  Song Yi Ko; Honami Naora
Journal:  Cancer Cell Microenviron       Date:  2014-11-13

4.  Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

Authors:  Hua Jiang; Xiaolong Lin; Yingtao Liu; Wenjia Gong; Xiaoling Ma; Yinhua Yu; Yi Xie; Xiaoxi Sun; Youji Feng; Viktor Janzen; Tong Chen
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

5.  Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.

Authors:  Isabelle Matte; Clara Major Legault; Perrine Garde-Granger; Claude Laplante; Paul Bessette; Claudine Rancourt; Alain Piché
Journal:  Clin Exp Metastasis       Date:  2016-09-09       Impact factor: 5.150

6.  P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.

Authors:  Akihiro Usui; Song Yi Ko; Nicolas Barengo; Honami Naora
Journal:  Mol Cancer Res       Date:  2014-01-21       Impact factor: 5.852

7.  MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.

Authors:  Panagiota Giannakouros; Marina Comamala; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

8.  Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice.

Authors:  A L Veatch; L F Carson; S Ramakrishnan
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

9.  Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Authors:  Kenjiro Sawada; Anirban K Mitra; A Reza Radjabi; Vinay Bhaskar; Emily O Kistner; Maria Tretiakova; Sujatha Jagadeeswaran; Anthony Montag; Amy Becker; Hilary A Kenny; Marcus E Peter; Vanitha Ramakrishnan; S Diane Yamada; Ernst Lengyel
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 10.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.